 | • レポートコード：GIR-23F3900 • 出版社/出版日：GlobalInfoResearch / 2023年2月 • レポート形態：英文、PDF、96ページ • 納品方法：Eメール（2~3営業日） • 産業分類：医薬品 |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥783,000 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 「Global Porcine Epidemic Diarrhea Vaccines Market」レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。 グローバルインフォリサーチ社（香港）の最新の調査によると、世界の豚流行性下痢ワクチンの市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。 豚流行性下痢ワクチン市場はタイプ（種類）とアプリケーション（用途）によって区分されます。2017年～2028年において、量と金額の観点からタイプ別およびアプリケーション別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。 タイプ別セグメントは次を対象にします。 ・生ワクチン、不活化ワクチン アプリケーション別セグメントは次のように区分されます。 ・子豚用、成豚用 世界の豚流行性下痢ワクチン市場の主要なマーケットプレーヤーは以下のとおりです。 ・CAVAC、Green Cross Veterinary Products、Harrisvaccines、Komipharm、Nisseiken、Qilu Animal Health、Zoetis 地域別セグメントは次の地域・国を対象にします。 ・北米市場（米国、カナダ、メキシコ） ・ヨーロッパ市場（ドイツ、フランス、イギリス、ロシア、イタリア） ・アジア太平洋市場（日本、中国、韓国、インド、東南アジア、オーストラリア） ・南米市場（ブラジル、アルゼンチン、コロンビア） ・中東・アフリカ市場（サウジアラビア、UAE、エジプト、南アフリカ） ***** 目次(一部) ***** ・市場概要 - 豚流行性下痢ワクチンの概要 - タイプ別分析（2017年vs2021年vs2028年）：生ワクチン、不活化ワクチン - アプリケーション別分析（2017年vs2021年vs2028年）：子豚用、成豚用 - 世界の豚流行性下痢ワクチン市場規模・予測 - 世界の豚流行性下痢ワクチン生産能力分析 - 市場の成長要因・阻害要因・動向 ・メーカー情報（企業概要、製品概要、販売量、価格、売上） - CAVAC、Green Cross Veterinary Products、Harrisvaccines、Komipharm、Nisseiken、Qilu Animal Health、Zoetis ・メーカー別市場シェア・市場集中度 ・地域別市場分析2017年-2028年 ・タイプ別分析2017年-2028年：生ワクチン、不活化ワクチン ・アプリケーション別分析2017年-2028年：子豚用、成豚用 ・豚流行性下痢ワクチンの北米市場分析 - 豚流行性下痢ワクチンの北米市場：タイプ別市場規模2017年-2028年 - 豚流行性下痢ワクチンの北米市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：アメリカ、カナダ、メキシコなど ・豚流行性下痢ワクチンのヨーロッパ市場分析 - ：豚流行性下痢ワクチンのヨーロッパ市場：タイプ別市場規模2017年-2028年 - ：豚流行性下痢ワクチンのヨーロッパ市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど ・豚流行性下痢ワクチンのアジア太平洋市場分析 - 豚流行性下痢ワクチンのアジア太平洋市場：タイプ別市場規模2017年-2028年 - 豚流行性下痢ワクチンのアジア太平洋市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど ・豚流行性下痢ワクチンの南米市場分析 - 豚流行性下痢ワクチンの南米市場：タイプ別市場規模2017年-2028年 - 豚流行性下痢ワクチンの南米市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：ブラジル、アルゼンチンなど ・豚流行性下痢ワクチンの中東・アフリカ市場分析 - 豚流行性下痢ワクチンの中東・アフリカ市場：タイプ別市場規模2017年-2028年 - 豚流行性下痢ワクチンの中東・アフリカ市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど ・原材料および産業チェーン ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Porcine Epidemic Diarrhea Vaccines market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Porcine Epidemic Diarrhea Vaccines market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Piglets accounting for % of the Porcine Epidemic Diarrhea Vaccines global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Live Vaccines segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Porcine Epidemic Diarrhea Vaccines include CAVAC, Green Cross Veterinary Products, Harrisvaccines, Komipharm, and Nisseiken, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Porcine Epidemic Diarrhea Vaccines market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Live Vaccines
Killed Vaccines
Market segment by Application can be divided into
Piglets
Adults Pigs
The key market players for global Porcine Epidemic Diarrhea Vaccines market are listed below:
CAVAC
Green Cross Veterinary Products
Harrisvaccines
Komipharm
Nisseiken
Qilu Animal Health
Zoetis
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Porcine Epidemic Diarrhea Vaccines product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Porcine Epidemic Diarrhea Vaccines, with price, sales, revenue and global market share of Porcine Epidemic Diarrhea Vaccines from 2019 to 2022.
Chapter 3, the Porcine Epidemic Diarrhea Vaccines competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Porcine Epidemic Diarrhea Vaccines breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Porcine Epidemic Diarrhea Vaccines market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Porcine Epidemic Diarrhea Vaccines.
Chapter 13, 14, and 15, to describe Porcine Epidemic Diarrhea Vaccines sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Porcine Epidemic Diarrhea Vaccines Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Porcine Epidemic Diarrhea Vaccines Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Live Vaccines
1.2.3 Killed Vaccines
1.3 Market Analysis by Application
1.3.1 Overview: Global Porcine Epidemic Diarrhea Vaccines Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Piglets
1.3.3 Adults Pigs
1.4 Global Porcine Epidemic Diarrhea Vaccines Market Size & Forecast
1.4.1 Global Porcine Epidemic Diarrhea Vaccines Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Porcine Epidemic Diarrhea Vaccines Sales in Volume (2017-2028)
1.4.3 Global Porcine Epidemic Diarrhea Vaccines Price (2017-2028)
1.5 Global Porcine Epidemic Diarrhea Vaccines Production Capacity Analysis
1.5.1 Global Porcine Epidemic Diarrhea Vaccines Total Production Capacity (2017-2028)
1.5.2 Global Porcine Epidemic Diarrhea Vaccines Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Porcine Epidemic Diarrhea Vaccines Market Drivers
1.6.2 Porcine Epidemic Diarrhea Vaccines Market Restraints
1.6.3 Porcine Epidemic Diarrhea Vaccines Trends Analysis
2 Manufacturers Profiles
2.1 CAVAC
2.1.1 CAVAC Details
2.1.2 CAVAC Major Business
2.1.3 CAVAC Porcine Epidemic Diarrhea Vaccines Product and Services
2.1.4 CAVAC Porcine Epidemic Diarrhea Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Green Cross Veterinary Products
2.2.1 Green Cross Veterinary Products Details
2.2.2 Green Cross Veterinary Products Major Business
2.2.3 Green Cross Veterinary Products Porcine Epidemic Diarrhea Vaccines Product and Services
2.2.4 Green Cross Veterinary Products Porcine Epidemic Diarrhea Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Harrisvaccines
2.3.1 Harrisvaccines Details
2.3.2 Harrisvaccines Major Business
2.3.3 Harrisvaccines Porcine Epidemic Diarrhea Vaccines Product and Services
2.3.4 Harrisvaccines Porcine Epidemic Diarrhea Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Komipharm
2.4.1 Komipharm Details
2.4.2 Komipharm Major Business
2.4.3 Komipharm Porcine Epidemic Diarrhea Vaccines Product and Services
2.4.4 Komipharm Porcine Epidemic Diarrhea Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Nisseiken
2.5.1 Nisseiken Details
2.5.2 Nisseiken Major Business
2.5.3 Nisseiken Porcine Epidemic Diarrhea Vaccines Product and Services
2.5.4 Nisseiken Porcine Epidemic Diarrhea Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Qilu Animal Health
2.6.1 Qilu Animal Health Details
2.6.2 Qilu Animal Health Major Business
2.6.3 Qilu Animal Health Porcine Epidemic Diarrhea Vaccines Product and Services
2.6.4 Qilu Animal Health Porcine Epidemic Diarrhea Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Zoetis
2.7.1 Zoetis Details
2.7.2 Zoetis Major Business
2.7.3 Zoetis Porcine Epidemic Diarrhea Vaccines Product and Services
2.7.4 Zoetis Porcine Epidemic Diarrhea Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Porcine Epidemic Diarrhea Vaccines Breakdown Data by Manufacturer
3.1 Global Porcine Epidemic Diarrhea Vaccines Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Porcine Epidemic Diarrhea Vaccines Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Porcine Epidemic Diarrhea Vaccines
3.4 Market Concentration Rate
3.4.1 Top 3 Porcine Epidemic Diarrhea Vaccines Manufacturer Market Share in 2021
3.4.2 Top 6 Porcine Epidemic Diarrhea Vaccines Manufacturer Market Share in 2021
3.5 Global Porcine Epidemic Diarrhea Vaccines Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Porcine Epidemic Diarrhea Vaccines Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Porcine Epidemic Diarrhea Vaccines Market Size by Region
4.1.1 Global Porcine Epidemic Diarrhea Vaccines Sales in Volume by Region (2017-2028)
4.1.2 Global Porcine Epidemic Diarrhea Vaccines Revenue by Region (2017-2028)
4.2 North America Porcine Epidemic Diarrhea Vaccines Revenue (2017-2028)
4.3 Europe Porcine Epidemic Diarrhea Vaccines Revenue (2017-2028)
4.4 Asia-Pacific Porcine Epidemic Diarrhea Vaccines Revenue (2017-2028)
4.5 South America Porcine Epidemic Diarrhea Vaccines Revenue (2017-2028)
4.6 Middle East and Africa Porcine Epidemic Diarrhea Vaccines Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Porcine Epidemic Diarrhea Vaccines Sales in Volume by Type (2017-2028)
5.2 Global Porcine Epidemic Diarrhea Vaccines Revenue by Type (2017-2028)
5.3 Global Porcine Epidemic Diarrhea Vaccines Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Porcine Epidemic Diarrhea Vaccines Sales in Volume by Application (2017-2028)
6.2 Global Porcine Epidemic Diarrhea Vaccines Revenue by Application (2017-2028)
6.3 Global Porcine Epidemic Diarrhea Vaccines Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Porcine Epidemic Diarrhea Vaccines Sales by Type (2017-2028)
7.2 North America Porcine Epidemic Diarrhea Vaccines Sales by Application (2017-2028)
7.3 North America Porcine Epidemic Diarrhea Vaccines Market Size by Country
7.3.1 North America Porcine Epidemic Diarrhea Vaccines Sales in Volume by Country (2017-2028)
7.3.2 North America Porcine Epidemic Diarrhea Vaccines Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Porcine Epidemic Diarrhea Vaccines Sales by Type (2017-2028)
8.2 Europe Porcine Epidemic Diarrhea Vaccines Sales by Application (2017-2028)
8.3 Europe Porcine Epidemic Diarrhea Vaccines Market Size by Country
8.3.1 Europe Porcine Epidemic Diarrhea Vaccines Sales in Volume by Country (2017-2028)
8.3.2 Europe Porcine Epidemic Diarrhea Vaccines Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Porcine Epidemic Diarrhea Vaccines Sales by Type (2017-2028)
9.2 Asia-Pacific Porcine Epidemic Diarrhea Vaccines Sales by Application (2017-2028)
9.3 Asia-Pacific Porcine Epidemic Diarrhea Vaccines Market Size by Region
9.3.1 Asia-Pacific Porcine Epidemic Diarrhea Vaccines Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Porcine Epidemic Diarrhea Vaccines Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Porcine Epidemic Diarrhea Vaccines Sales by Type (2017-2028)
10.2 South America Porcine Epidemic Diarrhea Vaccines Sales by Application (2017-2028)
10.3 South America Porcine Epidemic Diarrhea Vaccines Market Size by Country
10.3.1 South America Porcine Epidemic Diarrhea Vaccines Sales in Volume by Country (2017-2028)
10.3.2 South America Porcine Epidemic Diarrhea Vaccines Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Porcine Epidemic Diarrhea Vaccines Sales by Type (2017-2028)
11.2 Middle East & Africa Porcine Epidemic Diarrhea Vaccines Sales by Application (2017-2028)
11.3 Middle East & Africa Porcine Epidemic Diarrhea Vaccines Market Size by Country
11.3.1 Middle East & Africa Porcine Epidemic Diarrhea Vaccines Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Porcine Epidemic Diarrhea Vaccines Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Porcine Epidemic Diarrhea Vaccines and Key Manufacturers
12.2 Manufacturing Costs Percentage of Porcine Epidemic Diarrhea Vaccines
12.3 Porcine Epidemic Diarrhea Vaccines Production Process
12.4 Porcine Epidemic Diarrhea Vaccines Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Porcine Epidemic Diarrhea Vaccines Typical Distributors
13.3 Porcine Epidemic Diarrhea Vaccines Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer
Table 1. Global Porcine Epidemic Diarrhea Vaccines Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Porcine Epidemic Diarrhea Vaccines Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. CAVAC Basic Information, Manufacturing Base and Competitors
Table 4. CAVAC Major Business
Table 5. CAVAC Porcine Epidemic Diarrhea Vaccines Product and Services
Table 6. CAVAC Porcine Epidemic Diarrhea Vaccines Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Green Cross Veterinary Products Basic Information, Manufacturing Base and Competitors
Table 8. Green Cross Veterinary Products Major Business
Table 9. Green Cross Veterinary Products Porcine Epidemic Diarrhea Vaccines Product and Services
Table 10. Green Cross Veterinary Products Porcine Epidemic Diarrhea Vaccines Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Harrisvaccines Basic Information, Manufacturing Base and Competitors
Table 12. Harrisvaccines Major Business
Table 13. Harrisvaccines Porcine Epidemic Diarrhea Vaccines Product and Services
Table 14. Harrisvaccines Porcine Epidemic Diarrhea Vaccines Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Komipharm Basic Information, Manufacturing Base and Competitors
Table 16. Komipharm Major Business
Table 17. Komipharm Porcine Epidemic Diarrhea Vaccines Product and Services
Table 18. Komipharm Porcine Epidemic Diarrhea Vaccines Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Nisseiken Basic Information, Manufacturing Base and Competitors
Table 20. Nisseiken Major Business
Table 21. Nisseiken Porcine Epidemic Diarrhea Vaccines Product and Services
Table 22. Nisseiken Porcine Epidemic Diarrhea Vaccines Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Qilu Animal Health Basic Information, Manufacturing Base and Competitors
Table 24. Qilu Animal Health Major Business
Table 25. Qilu Animal Health Porcine Epidemic Diarrhea Vaccines Product and Services
Table 26. Qilu Animal Health Porcine Epidemic Diarrhea Vaccines Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Zoetis Basic Information, Manufacturing Base and Competitors
Table 28. Zoetis Major Business
Table 29. Zoetis Porcine Epidemic Diarrhea Vaccines Product and Services
Table 30. Zoetis Porcine Epidemic Diarrhea Vaccines Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Global Porcine Epidemic Diarrhea Vaccines Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 32. Global Porcine Epidemic Diarrhea Vaccines Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 33. Market Position of Manufacturers in Porcine Epidemic Diarrhea Vaccines, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 34. Global Porcine Epidemic Diarrhea Vaccines Production Capacity by Company, (K Units): 2020 VS 2021
Table 35. Head Office and Porcine Epidemic Diarrhea Vaccines Production Site of Key Manufacturer
Table 36. Porcine Epidemic Diarrhea Vaccines New Entrant and Capacity Expansion Plans
Table 37. Porcine Epidemic Diarrhea Vaccines Mergers & Acquisitions in the Past Five Years
Table 38. Global Porcine Epidemic Diarrhea Vaccines Sales by Region (2017-2022) & (K Units)
Table 39. Global Porcine Epidemic Diarrhea Vaccines Sales by Region (2023-2028) & (K Units)
Table 40. Global Porcine Epidemic Diarrhea Vaccines Revenue by Region (2017-2022) & (USD Million)
Table 41. Global Porcine Epidemic Diarrhea Vaccines Revenue by Region (2023-2028) & (USD Million)
Table 42. Global Porcine Epidemic Diarrhea Vaccines Sales by Type (2017-2022) & (K Units)
Table 43. Global Porcine Epidemic Diarrhea Vaccines Sales by Type (2023-2028) & (K Units)
Table 44. Global Porcine Epidemic Diarrhea Vaccines Revenue by Type (2017-2022) & (USD Million)
Table 45. Global Porcine Epidemic Diarrhea Vaccines Revenue by Type (2023-2028) & (USD Million)
Table 46. Global Porcine Epidemic Diarrhea Vaccines Price by Type (2017-2022) & (USD/Unit)
Table 47. Global Porcine Epidemic Diarrhea Vaccines Price by Type (2023-2028) & (USD/Unit)
Table 48. Global Porcine Epidemic Diarrhea Vaccines Sales by Application (2017-2022) & (K Units)
Table 49. Global Porcine Epidemic Diarrhea Vaccines Sales by Application (2023-2028) & (K Units)
Table 50. Global Porcine Epidemic Diarrhea Vaccines Revenue by Application (2017-2022) & (USD Million)
Table 51. Global Porcine Epidemic Diarrhea Vaccines Revenue by Application (2023-2028) & (USD Million)
Table 52. Global Porcine Epidemic Diarrhea Vaccines Price by Application (2017-2022) & (USD/Unit)
Table 53. Global Porcine Epidemic Diarrhea Vaccines Price by Application (2023-2028) & (USD/Unit)
Table 54. North America Porcine Epidemic Diarrhea Vaccines Sales by Country (2017-2022) & (K Units)
Table 55. North America Porcine Epidemic Diarrhea Vaccines Sales by Country (2023-2028) & (K Units)
Table 56. North America Porcine Epidemic Diarrhea Vaccines Revenue by Country (2017-2022) & (USD Million)
Table 57. North America Porcine Epidemic Diarrhea Vaccines Revenue by Country (2023-2028) & (USD Million)
Table 58. North America Porcine Epidemic Diarrhea Vaccines Sales by Type (2017-2022) & (K Units)
Table 59. North America Porcine Epidemic Diarrhea Vaccines Sales by Type (2023-2028) & (K Units)
Table 60. North America Porcine Epidemic Diarrhea Vaccines Sales by Application (2017-2022) & (K Units)
Table 61. North America Porcine Epidemic Diarrhea Vaccines Sales by Application (2023-2028) & (K Units)
Table 62. Europe Porcine Epidemic Diarrhea Vaccines Sales by Country (2017-2022) & (K Units)
Table 63. Europe Porcine Epidemic Diarrhea Vaccines Sales by Country (2023-2028) & (K Units)
Table 64. Europe Porcine Epidemic Diarrhea Vaccines Revenue by Country (2017-2022) & (USD Million)
Table 65. Europe Porcine Epidemic Diarrhea Vaccines Revenue by Country (2023-2028) & (USD Million)
Table 66. Europe Porcine Epidemic Diarrhea Vaccines Sales by Type (2017-2022) & (K Units)
Table 67. Europe Porcine Epidemic Diarrhea Vaccines Sales by Type (2023-2028) & (K Units)
Table 68. Europe Porcine Epidemic Diarrhea Vaccines Sales by Application (2017-2022) & (K Units)
Table 69. Europe Porcine Epidemic Diarrhea Vaccines Sales by Application (2023-2028) & (K Units)
Table 70. Asia-Pacific Porcine Epidemic Diarrhea Vaccines Sales by Region (2017-2022) & (K Units)
Table 71. Asia-Pacific Porcine Epidemic Diarrhea Vaccines Sales by Region (2023-2028) & (K Units)
Table 72. Asia-Pacific Porcine Epidemic Diarrhea Vaccines Revenue by Region (2017-2022) & (USD Million)
Table 73. Asia-Pacific Porcine Epidemic Diarrhea Vaccines Revenue by Region (2023-2028) & (USD Million)
Table 74. Asia-Pacific Porcine Epidemic Diarrhea Vaccines Sales by Type (2017-2022) & (K Units)
Table 75. Asia-Pacific Porcine Epidemic Diarrhea Vaccines Sales by Type (2023-2028) & (K Units)
Table 76. Asia-Pacific Porcine Epidemic Diarrhea Vaccines Sales by Application (2017-2022) & (K Units)
Table 77. Asia-Pacific Porcine Epidemic Diarrhea Vaccines Sales by Application (2023-2028) & (K Units)
Table 78. South America Porcine Epidemic Diarrhea Vaccines Sales by Country (2017-2022) & (K Units)
Table 79. South America Porcine Epidemic Diarrhea Vaccines Sales by Country (2023-2028) & (K Units)
Table 80. South America Porcine Epidemic Diarrhea Vaccines Revenue by Country (2017-2022) & (USD Million)
Table 81. South America Porcine Epidemic Diarrhea Vaccines Revenue by Country (2023-2028) & (USD Million)
Table 82. South America Porcine Epidemic Diarrhea Vaccines Sales by Type (2017-2022) & (K Units)
Table 83. South America Porcine Epidemic Diarrhea Vaccines Sales by Type (2023-2028) & (K Units)
Table 84. South America Porcine Epidemic Diarrhea Vaccines Sales by Application (2017-2022) & (K Units)
Table 85. South America Porcine Epidemic Diarrhea Vaccines Sales by Application (2023-2028) & (K Units)
Table 86. Middle East & Africa Porcine Epidemic Diarrhea Vaccines Sales by Region (2017-2022) & (K Units)
Table 87. Middle East & Africa Porcine Epidemic Diarrhea Vaccines Sales by Region (2023-2028) & (K Units)
Table 88. Middle East & Africa Porcine Epidemic Diarrhea Vaccines Revenue by Region (2017-2022) & (USD Million)
Table 89. Middle East & Africa Porcine Epidemic Diarrhea Vaccines Revenue by Region (2023-2028) & (USD Million)
Table 90. Middle East & Africa Porcine Epidemic Diarrhea Vaccines Sales by Type (2017-2022) & (K Units)
Table 91. Middle East & Africa Porcine Epidemic Diarrhea Vaccines Sales by Type (2023-2028) & (K Units)
Table 92. Middle East & Africa Porcine Epidemic Diarrhea Vaccines Sales by Application (2017-2022) & (K Units)
Table 93. Middle East & Africa Porcine Epidemic Diarrhea Vaccines Sales by Application (2023-2028) & (K Units)
Table 94. Porcine Epidemic Diarrhea Vaccines Raw Material
Table 95. Key Manufacturers of Porcine Epidemic Diarrhea Vaccines Raw Materials
Table 96. Direct Channel Pros & Cons
Table 97. Indirect Channel Pros & Cons
Table 98. Porcine Epidemic Diarrhea Vaccines Typical Distributors
Table 99. Porcine Epidemic Diarrhea Vaccines Typical Customers
List of Figures
Figure 1. Porcine Epidemic Diarrhea Vaccines Picture
Figure 2. Global Porcine Epidemic Diarrhea Vaccines Revenue Market Share by Type in 2021
Figure 3. Live Vaccines
Figure 4. Killed Vaccines
Figure 5. Global Porcine Epidemic Diarrhea Vaccines Revenue Market Share by Application in 2021
Figure 6. Piglets
Figure 7. Adults Pigs
Figure 8. Global Porcine Epidemic Diarrhea Vaccines Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 9. Global Porcine Epidemic Diarrhea Vaccines Revenue and Forecast (2017-2028) & (USD Million)
Figure 10. Global Porcine Epidemic Diarrhea Vaccines Sales (2017-2028) & (K Units)
Figure 11. Global Porcine Epidemic Diarrhea Vaccines Price (2017-2028) & (USD/Unit)
Figure 12. Global Porcine Epidemic Diarrhea Vaccines Production Capacity (2017-2028) & (K Units)
Figure 13. Global Porcine Epidemic Diarrhea Vaccines Production Capacity by Geographic Region: 2022 VS 2028
Figure 14. Porcine Epidemic Diarrhea Vaccines Market Drivers
Figure 15. Porcine Epidemic Diarrhea Vaccines Market Restraints
Figure 16. Porcine Epidemic Diarrhea Vaccines Market Trends
Figure 17. Global Porcine Epidemic Diarrhea Vaccines Sales Market Share by Manufacturer in 2021
Figure 18. Global Porcine Epidemic Diarrhea Vaccines Revenue Market Share by Manufacturer in 2021
Figure 19. Porcine Epidemic Diarrhea Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 20. Top 3 Porcine Epidemic Diarrhea Vaccines Manufacturer (Revenue) Market Share in 2021
Figure 21. Top 6 Porcine Epidemic Diarrhea Vaccines Manufacturer (Revenue) Market Share in 2021
Figure 22. Global Porcine Epidemic Diarrhea Vaccines Sales Market Share by Region (2017-2028)
Figure 23. Global Porcine Epidemic Diarrhea Vaccines Revenue Market Share by Region (2017-2028)
Figure 24. North America Porcine Epidemic Diarrhea Vaccines Revenue (2017-2028) & (USD Million)
Figure 25. Europe Porcine Epidemic Diarrhea Vaccines Revenue (2017-2028) & (USD Million)
Figure 26. Asia-Pacific Porcine Epidemic Diarrhea Vaccines Revenue (2017-2028) & (USD Million)
Figure 27. South America Porcine Epidemic Diarrhea Vaccines Revenue (2017-2028) & (USD Million)
Figure 28. Middle East & Africa Porcine Epidemic Diarrhea Vaccines Revenue (2017-2028) & (USD Million)
Figure 29. Global Porcine Epidemic Diarrhea Vaccines Sales Market Share by Type (2017-2028)
Figure 30. Global Porcine Epidemic Diarrhea Vaccines Revenue Market Share by Type (2017-2028)
Figure 31. Global Porcine Epidemic Diarrhea Vaccines Price by Type (2017-2028) & (USD/Unit)
Figure 32. Global Porcine Epidemic Diarrhea Vaccines Sales Market Share by Application (2017-2028)
Figure 33. Global Porcine Epidemic Diarrhea Vaccines Revenue Market Share by Application (2017-2028)
Figure 34. Global Porcine Epidemic Diarrhea Vaccines Price by Application (2017-2028) & (USD/Unit)
Figure 35. North America Porcine Epidemic Diarrhea Vaccines Sales Market Share by Type (2017-2028)
Figure 36. North America Porcine Epidemic Diarrhea Vaccines Sales Market Share by Application (2017-2028)
Figure 37. North America Porcine Epidemic Diarrhea Vaccines Sales Market Share by Country (2017-2028)
Figure 38. North America Porcine Epidemic Diarrhea Vaccines Revenue Market Share by Country (2017-2028)
Figure 39. United States Porcine Epidemic Diarrhea Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 40. Canada Porcine Epidemic Diarrhea Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 41. Mexico Porcine Epidemic Diarrhea Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Europe Porcine Epidemic Diarrhea Vaccines Sales Market Share by Type (2017-2028)
Figure 43. Europe Porcine Epidemic Diarrhea Vaccines Sales Market Share by Application (2017-2028)
Figure 44. Europe Porcine Epidemic Diarrhea Vaccines Sales Market Share by Country (2017-2028)
Figure 45. Europe Porcine Epidemic Diarrhea Vaccines Revenue Market Share by Country (2017-2028)
Figure 46. Germany Porcine Epidemic Diarrhea Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 47. France Porcine Epidemic Diarrhea Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. United Kingdom Porcine Epidemic Diarrhea Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. Russia Porcine Epidemic Diarrhea Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. Italy Porcine Epidemic Diarrhea Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Asia-Pacific Porcine Epidemic Diarrhea Vaccines Sales Market Share by Region (2017-2028)
Figure 52. Asia-Pacific Porcine Epidemic Diarrhea Vaccines Sales Market Share by Application (2017-2028)
Figure 53. Asia-Pacific Porcine Epidemic Diarrhea Vaccines Sales Market Share by Region (2017-2028)
Figure 54. Asia-Pacific Porcine Epidemic Diarrhea Vaccines Revenue Market Share by Region (2017-2028)
Figure 55. China Porcine Epidemic Diarrhea Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. Japan Porcine Epidemic Diarrhea Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Korea Porcine Epidemic Diarrhea Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. India Porcine Epidemic Diarrhea Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Southeast Asia Porcine Epidemic Diarrhea Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Australia Porcine Epidemic Diarrhea Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. South America Porcine Epidemic Diarrhea Vaccines Sales Market Share by Type (2017-2028)
Figure 62. South America Porcine Epidemic Diarrhea Vaccines Sales Market Share by Application (2017-2028)
Figure 63. South America Porcine Epidemic Diarrhea Vaccines Sales Market Share by Country (2017-2028)
Figure 64. South America Porcine Epidemic Diarrhea Vaccines Revenue Market Share by Country (2017-2028)
Figure 65. Brazil Porcine Epidemic Diarrhea Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. Argentina Porcine Epidemic Diarrhea Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Middle East & Africa Porcine Epidemic Diarrhea Vaccines Sales Market Share by Type (2017-2028)
Figure 68. Middle East & Africa Porcine Epidemic Diarrhea Vaccines Sales Market Share by Application (2017-2028)
Figure 69. Middle East & Africa Porcine Epidemic Diarrhea Vaccines Sales Market Share by Region (2017-2028)
Figure 70. Middle East & Africa Porcine Epidemic Diarrhea Vaccines Revenue Market Share by Region (2017-2028)
Figure 71. Turkey Porcine Epidemic Diarrhea Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 72. Egypt Porcine Epidemic Diarrhea Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Saudi Arabia Porcine Epidemic Diarrhea Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. South Africa Porcine Epidemic Diarrhea Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Manufacturing Cost Structure Analysis of Porcine Epidemic Diarrhea Vaccines in 2021
Figure 76. Manufacturing Process Analysis of Porcine Epidemic Diarrhea Vaccines
Figure 77. Porcine Epidemic Diarrhea Vaccines Industrial Chain
Figure 78. Sales Channel: Direct Channel vs Indirect Channel
Figure 79. Methodology
Figure 80. Research Process and Data Source